These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27810441)

  • 1. Lipid-modified oligonucleotide conjugates: Insights into gene silencing, interaction with model membranes and cellular uptake mechanisms.
    Ugarte-Uribe B; Grijalvo S; Pertíñez SN; Busto JV; Martín C; Alagia A; Goñi FM; Eritja R; Alkorta I
    Bioorg Med Chem; 2017 Jan; 25(1):175-186. PubMed ID: 27810441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer.
    Karaki S; Benizri S; Mejías R; Baylot V; Branger N; Nguyen T; Vialet B; Oumzil K; Barthélémy P; Rocchi P
    J Control Release; 2017 Jul; 258():1-9. PubMed ID: 28472637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian cells.
    Ugarte-Uribe B; Grijalvo S; Busto JV; Martín C; Eritja R; Goñi FM; Alkorta I
    Biochim Biophys Acta; 2013 Oct; 1830(10):4872-84. PubMed ID: 23800579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified concatemeric oligonucleotide complexes: new system for efficient oligonucleotide transfer into mammalian cells.
    Gusachenko Simonova ON; Pishnyi DV; Vlassov VV; Zenkova M
    Hum Gene Ther; 2008 May; 19(5):532-46. PubMed ID: 18457543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells.
    Vinogradov S; Batrakova E; Li S; Kabanov A
    Bioconjug Chem; 1999; 10(5):851-60. PubMed ID: 10502353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
    Ghosh C; Iversen PL
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):263-74. PubMed ID: 10984120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
    J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y; Franzen S
    Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of antisense oligonucleotides by molecular conjugates.
    Bunnell BA; Askari FK; Wilson JM
    Somat Cell Mol Genet; 1992 Nov; 18(6):559-69. PubMed ID: 1287854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
    Agrawal S
    Biochim Biophys Acta; 1999 Dec; 1489(1):53-68. PubMed ID: 10806997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.
    Grünweller A; Wyszko E; Bieber B; Jahnel R; Erdmann VA; Kurreck J
    Nucleic Acids Res; 2003 Jun; 31(12):3185-93. PubMed ID: 12799446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles.
    Conde J; de la Fuente JM; Baptista PV
    Nanotechnology; 2010 Dec; 21(50):505101. PubMed ID: 21098932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid membrane permeability of 2'-modified derivatives of phosphorothioate oligonucleotides.
    Hughes JA; Bennett CF; Cook PD; Guinosso CJ; Mirabelli CK; Juliano RL
    J Pharm Sci; 1994 Apr; 83(4):597-600. PubMed ID: 8046622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical and transdermal delivery of antisense oligonucleotides.
    Brand RM
    Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
    Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo metabolic profile of a phosphorothioate oligodeoxyribonucleotide.
    Temsamani J; Roskey A; Chaix C; Agrawal S
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):159-65. PubMed ID: 9212906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.